PCOS to PMOS Australia: symptoms, diagnosis, ovulation and fertility
In May 2026, polycystic ovary syndrome, or PCOS, was renamed polyendocrine metabolic ovarian syndrome, or PMOS. PCOS and PMOS describe the same condition, not two separate diagnoses.
This Australian PMOS guide explains the PCOS to PMOS name change, symptoms, diagnosis, ovulation, fertility, testing and care pathways. It also explains why older PCOS wording may still appear in records, referrals, pathology forms, ultrasound reports and trusted health information.
Use this guide to prepare clearer questions for your GP, gynaecologist, endocrinologist or fertility specialist. This information is for education only. It cannot diagnose symptoms, confirm or rule out PMOS, or replace personalised medical advice.
Medically reviewed by Evan Kurzyp, RN (AHPRA), BSN, Master of Nursing. AHPRA registration: NMW0002424871.
Last reviewed: . Next scheduled review: .
What PMOS means before you read further
PMOS stands for polyendocrine metabolic ovarian syndrome. It is the updated name for PCOS, but it is not a separate condition.
PMOS can involve hormone pathways, metabolic health, ovulation, menstrual cycles and ovarian features. Later sections explain symptoms, diagnosis, testing, fertility and care pathways in more detail.
What the name means
- Polyendocrine means more than one hormone pathway may be involved.
- Metabolic reflects links with insulin, blood sugar, cholesterol and longer-term metabolic health.
- Ovarian recognises that ovulation, menstrual cycles and ovarian features may also be part of the condition.
What PMOS can involve
PMOS can affect people in different ways. It may involve irregular or absent periods, ovulation changes, acne, excess facial or body hair, scalp hair thinning, fertility concerns, insulin resistance, metabolic health risks and emotional wellbeing.
Not everyone has the same symptoms.
How PMOS is assessed
PMOS is assessed by looking at the overall clinical pattern.
A clinician may consider cycle history, symptoms, androgen-related signs or blood-test results, ovarian findings where relevant, medications, age, health history and other conditions that can cause similar symptoms.
PCOS vs. PMOS: What Is the Difference?
In May 2026, PCOS was renamed PMOS. The condition has not changed. Polycystic ovary syndrome is now called polyendocrine metabolic ovarian syndrome.
The updated name is intended to describe the condition more accurately and reduce confusion caused by the older, cyst-focused wording.
Same condition, clearer framing
The name has changed, but the condition has not. If you were previously diagnosed with PCOS, that diagnosis does not become invalid because the terminology is changing.
The change is about how the condition is described, not a change in your body, symptoms or underlying risk profile.
What led to the name change?
When a condition name leads with “cysts”, attention can shift toward one feature rather than the full clinical picture.
For many people, this created confusion when symptoms extended beyond fertility or ultrasound findings. Patient and clinician research also identified delayed diagnosis and incomplete care as key reasons to support clearer terminology.
What did not change?
The name change does not change the diagnostic approach or the treatment options currently used in care. Research published under the PCOS name still applies to PMOS.
Clinical care should still be based on symptoms, cycle pattern, examination findings, blood tests, ultrasound findings where relevant, medical history, age, fertility goals and clinician assessment.
The three-year rollout
The transition from PCOS to PMOS is planned over three years. During this period, both names may appear in clinics, electronic records, lab reports, research papers and patient materials.
The 2028 International Guideline update is expected to fully use PMOS. Coding systems may update through separate formal processes.
PCOS/PMOS vs PCO, PCOM and high AMH
PCOS, PMOS, PCO, PCOM and high AMH can appear in the same appointment, pathology result or ultrasound report, but they do not mean the same thing.
PCOS and PMOS are names for the condition. PCO or PCOM describes ovarian appearance. High AMH is a blood-test finding that needs clinical context.
| Term | What it means | What to remember | How to interpret it |
|---|---|---|---|
| PCOS | Polycystic ovary syndrome. The older name still used in records, searches and many health resources. | Same condition now called PMOS. PCOS is not defined by ovarian appearance alone. | Read PCOS and PMOS wording together during the transition. |
| PMOS | Polyendocrine metabolic ovarian syndrome. The updated name for PCOS. | Better reflects endocrine, metabolic and ovarian features. It is not a separate diagnosis. | Use PMOS for current terminology and updated Australian resources. |
| PCO / PCOM | Polycystic ovaries or polycystic ovarian morphology. This describes ovarian appearance, usually on ultrasound. | Not the whole syndrome. Polycystic ovarian morphology can occur without PCOS or PMOS. | Interpret with cycle history, symptoms, androgen-related signs or blood tests, age and clinical assessment. |
| High AMH | A higher anti-Müllerian hormone result. AMH is measured in blood and relates to ovarian follicle activity. | May support assessment in some adults, but cannot diagnose PCOS or PMOS on its own. Age, medications, assay method and lab ranges matter. | Review with a GP or specialist, especially if cycles, symptoms or fertility questions are unclear. |
PCOS
Polycystic ovary syndromePMOS
Polyendocrine metabolic ovarian syndromePCO / PCOM
Polycystic ovaries / polycystic ovarian morphologyHigh AMH
Higher anti-Müllerian hormone resultOvulation calculator for PMOS and irregular cycles
This calculator gives a date-based estimate of your fertile window.
It may help you plan when to watch for fertile signs, time intercourse or interpret cycle tracking information, but it cannot confirm ovulation. It may be less reliable if your cycles are long, absent, very irregular or recently changed.
Ovulation calculator
Enter the first day of your last period and your usual cycle length to estimate your fertile window. You can also add LH test, basal body temperature or cervical mucus details if you track them.
PMOS tests and assessment overview
When PMOS is being considered, assessment usually starts with your cycle pattern, symptoms, medical history, medications, family history and whether pregnancy is possible.
Your GP may then discuss hormone blood tests, metabolic health checks, AMH, ultrasound or referral. The tests chosen depend on your symptoms, age, cycle pattern, health history and goals.
No single test confirms PMOS on its own.
Cycle and symptom history
Cycle history is often the first clue.
Your GP may ask how often your periods come, whether they are absent, very heavy or unpredictable, when symptoms began, and whether you have acne, increased facial or body hair, scalp hair thinning, weight change or fertility concerns.
This helps guide which investigations are relevant.
Pregnancy test if a period is late
If your period is late and pregnancy is possible, a pregnancy test may be relevant before assuming PMOS is the reason.
This may be a home urine test or a blood test arranged through a clinician.
A late period can also relate to stress, illness, weight change, medications, thyroid issues or other hormone changes.
Hormone blood tests
Hormone blood tests may be discussed to look for androgen patterns and other conditions that can cause similar symptoms.
These results are not interpreted alone. Timing, medications and hormonal contraception can affect what the results mean.
Your GP may also consider tests for thyroid, prolactin or other hormone-related causes, depending on your symptoms.
Metabolic health checks
PMOS can involve metabolic features as well as cycle, skin, hair and fertility-related symptoms.
Your GP may discuss blood glucose, cholesterol, blood pressure and other metabolic health markers. These checks help assess broader health risks, not just diagnosis.
Insulin resistance can be part of PMOS, but fasting insulin testing is not routinely needed for everyone.
AMH and ultrasound
AMH and ultrasound may be useful in context, especially when the clinical picture is unclear.
AMH can help assess ovarian follicle patterns in some adults. Ultrasound may look at ovarian appearance and other pelvic findings.
Neither AMH nor ultrasound is needed for every person. Age matters, and these results should be interpreted with symptoms, cycle pattern and androgen-related findings.
Referral discussion
Referral depends on your symptoms, goals, results and clinical judgement.
Your GP may discuss whether support from a gynaecologist, endocrinologist, fertility specialist, dietitian or other health professional is appropriate.
A GP discussion is the best next step if you are unsure which investigations apply to you.
PMOS fertility and ovulation pathway
Fertility questions in PMOS often come back to ovulation.
PMOS can change ovulation patterns for some people. This may make the fertile window harder to predict when cycles are long, absent or irregular.
This does not mean everyone with PMOS is infertile. Many people with PMOS can conceive naturally, while others may take longer or need clinical support.
How PMOS can affect ovulation
Ovulation is when an ovary releases an egg.
With PMOS, ovulation may happen later than expected, less often, or not in some cycles.
Calendar predictions work best when cycles are fairly regular. If cycle length changes from month to month, an app or calculator may place the fertile window too early or too late.
For irregular cycles, the key question is not only “when is my next period due?” It is also “are there signs that ovulation may be approaching?”
Track more than dates
Tracking ovulation with PMOS often means looking at more than one sign.
LH tests can show a rise in luteinising hormone before ovulation is likely. They do not confirm that ovulation happened, and they do not diagnose PMOS.
Cervical mucus may become clearer, wetter or more slippery before ovulation.
Basal body temperature may rise after ovulation, so it is more useful for recognising a pattern after the fact than choosing the best day in that cycle.
When to seek help
Consider speaking with your GP if your periods are absent, very irregular or difficult to track.
Also seek advice if pregnancy has not occurred after:
- 12 months of regular unprotected sex if you are under 35
- 6 months of regular unprotected sex if you are 35 or older
Seek advice earlier if you have known reproductive health concerns, very irregular cycles, symptoms that worry you, or if you are unsure whether you are ovulating.
A GP can help assess whether PMOS, ovulation, thyroid, prolactin, sperm factors or other causes should be considered.
PMOS resource library
Use these Australian guides to continue reading about PMOS, symptoms, testing, ovulation, fertility and metabolic health.
Choose the section that best matches your question. These resources are for education only and should support, not replace, advice from your GP, gynaecologist, endocrinologist or fertility specialist.
Newly diagnosed or checking symptoms2 guides
Start here if you are comparing terms, noticing symptoms or preparing questions for a GP.
Explains how PMOS is assessed, why PCO is not enough and how tests fit the wider clinical picture.
A symptom-focused guide for irregular cycles, skin and hair changes, fertility concerns and metabolic features.
Ovulation and cycle tracking5 guides
Use these guides when cycles are long, irregular or difficult to interpret.
Practical context for LH tests, cervical mucus, basal body temperature and irregular cycles.
Explains fertile window timing, egg survival, sperm survival and why the days before ovulation matter.
Explains what faint and dark ovulation test lines can and cannot show.
Explains why fertile-looking mucus is an oestrogen sign, not proof that ovulation has occurred.
Background reading on how temperature shifts can help recognise patterns after ovulation.
AMH, hormones and test results4 guides
Use these guides when a blood result, ultrasound report or hormone test raises questions.
Explains what AMH may and may not show in PMOS-related assessment.
Background reading on ovarian reserve, age, fertility context and AMH interpretation.
A hormone primer for understanding common cycle and fertility blood tests.
Useful when delayed cycles, negative tests and possible late ovulation need cautious follow-up.
Insulin resistance, food and supplement questions4 guides
These guides support conversations about metabolic checks, eating patterns and supplement questions.
A focused guide to insulin resistance, metabolic risk language and appointment questions.
Food and lifestyle context written cautiously for Australian readers.
A cautious overview of supplements people commonly ask about, including evidence limits and safety questions.
A specific guide to inositol, dosing questions, fertility context and limitations.
Fertility and specialist pathways6 guides
Use these guides when fertility goals, age, cycle pattern or test results suggest that more support may be useful.
A PMOS-focused pathway guide for ovulation, fertility planning, referral conversations and pregnancy context.
Explains when to see a GP or fertility specialist and what early assessment may involve.
A guide to GP referrals, specialist options, clinic factors and practical questions.
Explains why fertility assessment may involve sperm factors as well as ovulation and cycle health.
Background reading on intrauterine insemination and where it may fit in fertility care.
Explains how to interpret IVF statistics, including clinical pregnancy and live birth outcomes.
Pregnancy testing and late-cycle questions3 guides
These guides may help when ovulation timing is unclear and pregnancy testing feels confusing.
Explains testing too early, delayed ovulation, diluted urine and when to repeat testing or see a GP.
Explains why LH tests and pregnancy tests measure different hormones and why results need context.
Useful when ovulation timing is uncertain and a negative result may not yet be final.
PMOS and PCOS FAQs for Australia
These questions cover common points that may still be unclear after reading the guide, including regular periods, ultrasound wording, AMH, teenagers and when to seek clinical advice.
Can I have PMOS if my periods are regular?
Regular periods make ovulation problems less obvious, but they do not automatically rule out PMOS. Some people may still have androgen-related symptoms, metabolic features or ovarian findings that need clinical review. A GP or specialist can interpret your cycle pattern alongside symptoms, examination findings and test results.
Can I have PMOS without ovarian cysts?
Yes. PMOS is not diagnosed from “cysts” alone. Some people do not need an ultrasound to confirm the diagnosis, especially when irregular cycles and higher androgen features are already present. The small structures often described as “polycystic ovaries” are usually follicles, not the same as painful ovarian cysts that may need separate assessment.
What does PCOM mean on an ultrasound report?
PCOM stands for polycystic ovarian morphology. It describes how the ovaries look on ultrasound. It is not the same as having the full syndrome. PCOM can occur without PMOS, so the result should be interpreted with symptoms, cycle history, androgen-related signs or blood tests, age and clinical context.
What if my AMH result is high?
A high AMH result can reflect a higher number of small ovarian follicles, but it cannot diagnose PMOS on its own. In adults, AMH may sometimes help assess polycystic ovarian morphology as part of the broader diagnostic pathway. AMH is not generally recommended for diagnosing adolescents because results can overlap with normal reproductive development.
Is PMOS diagnosed differently in teenagers?
Yes. Diagnosis in adolescents is more cautious because irregular cycles and ovarian follicle patterns can be part of normal development after periods begin. Current international guidance requires both ovulatory dysfunction and hyperandrogenism in adolescents, and ultrasound or AMH are not recommended for diagnosis at this age.
Which doctor should I see first?
A GP is usually the best first step. They can review your symptoms, cycle history, medications, family history and whether pregnancy is possible. They may arrange initial blood tests, consider other causes of similar symptoms and discuss referral to a gynaecologist, endocrinologist, fertility specialist, dietitian or other health professional if needed.
Can PMOS be cured?
PMOS is usually managed rather than “cured”. Symptoms and health risks can often be improved with individualised care, which may include cycle management, skin or hair treatment, metabolic monitoring, lifestyle support or fertility care depending on your symptoms and goals.
What should I track before seeing a GP?
It can help to bring information about your period dates, cycle length, bleeding pattern, acne, hair growth, scalp hair thinning, weight changes, fertility goals, pregnancy test results and any medications or supplements you use. Copies of previous blood tests or ultrasound reports may also help your clinician see the pattern.
Medical review, references and updates
This Australian PMOS guide is reviewed for medical accuracy, source quality and practical relevance to Australian care pathways.
References and source method
Fertility2Family publishes Australia-focused fertility education. Articles are written by our team and medically reviewed by Australian-registered health practitioners.
We use Australian consumer medicine information, Australian clinical and public health guidance, and peer-reviewed research consistent with Australian care.
We explain what the evidence suggests, what it cannot confirm, and when to see a GP or fertility specialist. Each article lists its author, medical reviewer and review dates.
References used for this guide
- Australian Government Department of Health and Aged Care. Natural Therapies Review 2024: Naturopathy evidence evaluation.
This government-commissioned evidence evaluation includes a PCOS section, Australian prevalence context, common clinical features and higher reported prevalence in First Nations women. Relevance: Australian prevalence, symptom overview and equity context.
https://www.health.gov.au/sites/default/files/2025-03/natural-therapies-review-2024-naturopathy-evidence-evaluation.pdf - Australian Institute of Health and Welfare. The health of Australia’s females: Technical notes.
This Australian public-health source identifies national data gaps for female health conditions, including polycystic ovarian syndrome. Relevance: Australian public-health context and limitations in national PCOS data reporting.
https://www.aihw.gov.au/reports/women/female-health/contents/technical-notes - Australian Government Department of Health. National Women’s Health Strategy 2020–2030.
This national strategy recognises PCOS among women’s health conditions requiring improved access to services and better care pathways. Relevance: Australian policy context and the need for improved recognition, diagnosis and support.
https://www.health.gov.au/sites/default/files/documents/2021/05/national-women-s-health-strategy-2020-2030_0.pdf - Monash University. Polyendocrine Metabolic Ovarian Syndrome: New name to improve diagnosis and care of condition affecting 170 million women worldwide.
This Australian university release explains the PCOS to PMOS terminology change, why the older cyst-focused name caused confusion, and why the new name better reflects endocrine, metabolic and ovarian features. Relevance: PMOS rename, terminology transition and condition framing.
https://www.monash.edu/news/articles/polyendocrine-metabolic-ovarian-syndrome-new-name-to-improve-diagnosis-and-care-of-condition-affecting-170-million-women-worldwide - Monash Centre for Health Research and Implementation. PCOS Guideline and Resources.
This Australian-led guideline hub provides clinician and consumer resources connected to international evidence-based PCOS guidance. Relevance: Australian-led guideline resources and patient-centred PCOS/PMOS education.
https://www.monash.edu/medicine/mchri/pcos - Monash Centre for Health Research and Implementation. PCOS Guidelines.
This guideline page links to evidence-based recommendations for assessment and management of PCOS, including diagnosis, metabolic health, fertility and longer-term care. Relevance: diagnostic approach, testing, metabolic risk and fertility guidance.
https://www.monash.edu/medicine/mchri/pcos/guideline - Monash University. International evidence-based guideline for the assessment and management of polycystic ovary syndrome 2023: Summary.
This NHMRC-approved guideline summary outlines diagnostic criteria, adolescent diagnostic caution, AMH and ultrasound considerations, metabolic screening and fertility management principles. Relevance: adult diagnosis, adolescent assessment, AMH, ultrasound, metabolic risk and fertility care.
https://www.monash.edu/__data/assets/pdf_file/0003/3371133/PCOS-Guideline-Summary-2023.pdf - Medical Journal of Australia. Summary of the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome: an Australian perspective.
This Australian medical journal article interprets the 2023 international guideline for Australian clinical practice. Relevance: Australian clinical context, guideline implementation and GP/specialist care pathways.
https://www.mja.com.au/journal/2024/221/7/summary-2023-international-evidence-based-guideline-assessment-and-management - Journal of Clinical Endocrinology & Metabolism. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.
This peer-reviewed guideline publication summarises international recommendations on diagnosis, hyperandrogenism, AMH, ultrasound, metabolic health, mental health and fertility care. Relevance: evidence-based diagnostic nuance and clinical recommendations.
https://academic.oup.com/jcem/article/108/10/2447/7242360 - eClinicalMedicine. Polycystic ovary syndrome perspectives from patients and health professionals on clinical features, current name and renaming.
This international survey of patients and health professionals found strong support for renaming PCOS and identified delayed diagnosis and incomplete care as key concerns. Relevance: patient-centred reason for the PCOS to PMOS name change.
https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(25)00219-6/fulltext - The Lancet. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome.
This peer-reviewed publication explains the proposed PMOS name, why it better reflects the syndrome and how terminology transition is expected to occur. Relevance: formal PMOS terminology and international transition context.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00717-8/fulltext - RANZCOG. RANZCOG welcomes Polycystic Ovarian Syndrome renaming to Polyendocrine Metabolic Ovarian Syndrome.
This specialist-college statement supports the PCOS to PMOS rename and explains why the change may improve understanding of the condition beyond ovarian cysts. Relevance: Australian and New Zealand specialist endorsement of the terminology change.
https://ranzcog.edu.au/news/ranzcog-welcomes-polycystic-ovarian-syndrome-pcos-renaming-to-polyendocrine-metabolic-ovarian-syndrome-pmos/ - RACGP. PCOS officially renamed polyendocrine metabolic ovarian syndrome.
This Australian general-practice article explains the PCOS to PMOS rename for primary care and highlights the shift away from cyst-centred language. Relevance: GP-facing Australian terminology transition and primary-care context.
https://www1.racgp.org.au/newsgp/clinical/pcos-officially-renamed-polyendocrine-metabolic-ov - Jean Hailes for Women’s Health. Polycystic Ovary Syndrome.
This Australian women’s health resource explains PCOS/PMOS, symptoms, diagnosis, management and when to seek help in consumer-friendly language. Relevance: Australian consumer explanation of symptoms, diagnosis and care.
https://www.jeanhailes.org.au/health-topics/pcos/ - Jean Hailes for Women’s Health. How does PCOS affect fertility and pregnancy?
This resource explains how PCOS can affect ovulation, fertility planning and pregnancy considerations. Relevance: fertility and pregnancy context for people with PCOS/PMOS.
https://www.jeanhailes.org.au/health-topics/pcos/how-does-pcos-affect-fertility-and-pregnancy/ - healthdirect Australia. Polycystic ovarian syndrome.
This Australian Government-backed health portal summarises PCOS/PMOS symptoms, diagnosis, treatment, longer-term risks and the rename context. Relevance: Australian consumer definition, symptoms, long-term risks and PMOS transition.
https://www.healthdirect.gov.au/polycystic-ovarian-syndrome-pcos - healthdirect Australia. Irregular periods.
This Australian consumer health page explains common causes of irregular periods and when medical advice may be needed. Relevance: irregular-cycle context and GP review prompts.
https://www.healthdirect.gov.au/irregular-periods - healthdirect Australia. Menstruation.
This source explains normal menstrual-cycle function, period changes and cycle variation. Relevance: menstrual-cycle background for PMOS cycle and ovulation sections.
https://www.healthdirect.gov.au/menstruation - healthdirect Australia. Infertility.
This source explains infertility, common causes and when to seek medical advice. Relevance: fertility referral timing and when to seek clinical support.
https://www.healthdirect.gov.au/about-infertility - healthdirect Australia. Human chorionic gonadotropin test.
This consumer health source explains hCG testing and pregnancy-test context. Relevance: pregnancy-test distinction, late-cycle questions and avoiding misinterpretation of ovulation signs.
https://www.healthdirect.gov.au/hcg-test - healthdirect Australia. Thyroid function blood tests.
This source explains thyroid blood testing and why thyroid function may be assessed in some people with menstrual or hormone-related symptoms. Relevance: differential assessment for irregular cycles and blood-test context.
https://www.healthdirect.gov.au/thyroid-function-tests - Better Health Channel. Polycystic ovary syndrome.
This Victorian Government health resource explains PCOS symptoms, hormones, insulin resistance, weight, fertility and longer-term health considerations. Relevance: Australian public-health explanation of symptoms, insulin resistance and broader risk.
https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/polycystic-ovarian-syndrome-pcos - Better Health Channel. Ovulation and fertility.
This public-health resource explains ovulation, fertile-window timing and fertility basics. Relevance: ovulation calculator, fertile-window and fertility-pathway sections.
https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/ovulation - Better Health Channel. Infertility in women.
This resource explains female infertility, when to seek assessment and possible contributing factors. Relevance: fertility assessment and referral context.
https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/infertility-in-women - RACGP. Polycystic ovary syndrome: an update.
This Australian Family Physician article reviews PCOS prevalence, underdiagnosis, Rotterdam diagnostic criteria, metabolic risk and clinical management for general practice. Relevance: Australian GP diagnostic context, prevalence and metabolic risk.
https://www.racgp.org.au/afp/2012/october/polycystic-ovary-syndrome - Medical Journal of Australia. Prevalence of polycystic ovary syndrome in a sample of Indigenous women in Darwin, Australia.
This Australian study reported PCOS prevalence in a sample of Indigenous women and contributes to evidence on health inequity. Relevance: First Nations and Australian equity context.
https://www.mja.com.au/journal/2012/196/1/prevalence-polycystic-ovary-syndrome-sample-indigenous-women-darwin-australia - RANZCOG. Pre-pregnancy counselling clinical guideline.
This clinical guideline outlines pre-pregnancy counselling principles and health considerations before pregnancy. Relevance: preconception and fertility-care context for people seeking pregnancy with PMOS/PCOS.
https://ranzcog.edu.au/wp-content/uploads/Pre-Pregnancy-Counselling.pdf - Your Fertility. Polycystic Ovary Syndrome.
This Australian fertility education resource explains PCOS, ovulation, fertility and preconception health in plain language. Relevance: fertility planning, ovulation and trying-to-conceive context.
https://www.yourfertility.org.au/everyone/health-medical/polycystic-ovary-syndrome-pcos/ - Hormones Australia. Polycystic ovarian syndrome.
This endocrine-focused Australian resource explains PCOS, hormone features, symptoms and specialist-care considerations. Relevance: endocrine framing, symptoms and specialist pathway context.
https://www.hormones-australia.org.au/endocrine-diseases/polycystic-ovarian-syndrome-pcos/ - Dietitians Australia. Polycystic ovary syndrome.
This Australian professional association resource explains PCOS, insulin, androgens, cycle effects and lifestyle management in a dietetic context. Relevance: metabolic health, insulin resistance, diet and lifestyle context.
https://dietitiansaustralia.org.au/health-advice/polycystic-ovary-syndrome-pcos - Pathology Tests Explained. Anti-Mullerian Hormone.
This Australian pathology education resource explains AMH testing, what the result may show and why interpretation depends on clinical context. Relevance: AMH blood-test explanation and limitations.
https://ptex.au/ptests.php?q=Anti-Mullerian+Hormone+%28AMH%29 - Royal College of Pathologists of Australasia Manual. Anti-Mullerian hormone.
This pathology manual entry provides clinical-laboratory context for AMH testing and interpretation. Relevance: pathology context for AMH use in clinical assessment.
https://www.rcpa.edu.au/Manuals/RCPA-Manual/Pathology-Tests/A/Anti-Mullerian-hormone